![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
K Sathirakul, H Suzuki, T Yamada, M Hanano and Y Sugiyama
Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.
Multiplicity for the transport of organic anions across the bile canalicular membrane was studied in vivo and in vitro using dibromosulfophthalein (DBSP), [14C]cefodizime, [3H]leukotriene C4 (LTC4) and indocyanine green (ICG) as model compounds in rats. A high concentration of DBSP in plasma reduced the biliary excretion of cefodizime and leukotriene radioactivity to about 15 and 35% of their control values, respectively, but did not affect the excretion of ICG. A high plasma concentration of ICG reduced the excretion of cefodizime to about 60% of the control value, but exerted minimal effect on the excretion of leukotriene radio-activity and DBSP. In vitro, ATP- dependent uptake of LTC4 into the canalicular membrane vesicles was reduced by DBSP, cefodizime and ICG in a dose-dependent manner, with approximate IC50 values of 0.1 microM, 10 microM, and 1 microM, respectively. The hepatic unbound concentration of DBSP sufficient to reduce the excretion of cefodizime, leukotriene radioactivity and DBSP itself in vivo was calculated to be approximately 10 microM, a concentration which was also sufficient to reduce the transport of LTC4 in vitro. In contrast, the hepatic unbound concentration of ICG that saturated the excretion of ICG in vivo was calculated to be less than 0.1 microM, which was more than ten times smaller than the IC50 of ICG for the transport of LTC4 in vitro. These results suggest the presence of multiple systems for the transport of organic anions across the bile canalicular membrane: one is the predominant transport system for DBSP and cefodizime, which also accepts LTC4 as a substrate; the other is the primary transport system for ICG, which is distinct from that for DBSP, cefodizime and LTC4, although some overlap in the substrate specificity may be observed between the two systems.
This article has been cited by other articles:
|
|
 |
|
  M. Sasaki, H. Suzuki, J. Aoki, K. Ito, P. J. Meier, and Y. Sugiyama Prediction of in Vivo Biliary Clearance from the in Vitro Transcellular Transport of Organic Anions across a Double-Transfected Madin-Darby Canine Kidney II Monolayer Expressing Both Rat Organic Anion Transporting Polypeptide 4 and Multidrug Resistance Associated Protein 2 Mol. Pharmacol., September 1, 2004; 66(3): 450 - 459. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Van Bambeke, J.-M. Michot, and P. M. Tulkens Antibiotic efflux pumps in eukaryotic cells: occurrence and impact on antibiotic cellular pharmacokinetics, pharmacodynamics and toxicodynamics J. Antimicrob. Chemother., May 1, 2003; 51(5): 1067 - 1077. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Takenaga, M. Ishii, S. Nakajima, T. Hasegawa, R. Iwasa, H. Ishizaki, and T. Kamei In Vivo Metabolism of a New Anticancer Agent, 6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13-(beta -D-glucopyranosil)5H-indolo [2,3-a]pyrrolo [3,4-c]carbazole-5,7(6H)-dione (NB-506) in Rats and Dogs: Pharmacokinetics, Isolation, Identification, and Quantification of Metabolites Drug Metab. Dispos., February 1, 1999; 27(2): 205 - 212. [Abstract] [Full Text]
|
|
|
|
|
|
M. Murata, I. Tamai, Y. Sai, O. Nagata, H. Kato, Y. Sugiyama, and A. Tsuji Hepatobiliary Transport Kinetics of HSR-903, a New Quinolone Antibacterial Agent Drug Metab. Dispos., November 1, 1998; 26(11): 1113 - 1119. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. Yabuuchi, I. Tamai, K. Morita, T. Kouda, K.-I. Miyamoto, E. Takeda, and A. Tsuji Hepatic Sinusoidal Membrane Transport of Anionic Drugs Mediated by Anion Transporter Npt1 J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1391 - 1396. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. Ito, T. Iwatsubo, S. Kanamitsu, K. Ueda, H. Suzuki, and Y. Sugiyama Prediction of Pharmacokinetic Alterations Caused by Drug-Drug Interactions: Metabolic Interaction in the Liver Pharmacol. Rev., September 1, 1998; 50(3): 387 - 412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kusuhara, H. Suzuki, M. Naito, T. Tsuruo, and Y. Sugiyama Characterization of Efflux Transport of Organic Anions in a Mouse Brain Capillary Endothelial Cell Line J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1260 - 1265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hirohashi, H. Suzuki, K. Ito, K. Ogawa, K. Kume, T. Shimizu, and Y. Sugiyama Hepatic Expression of Multidrug Resistance-Associated Protein-Like Proteins Maintained in Eisai Hyperbilirubinemic Rats Mol. Pharmacol., June 1, 1998; 53(6): 1068 - 1075. [Abstract] [Full Text]
|
|
|
|
|
|
H. Sasabe, A. Tsuji, and Y. Sugiyama Carrier-Mediated Mechanism for the Biliary Excretion of the Quinolone Antibiotic Grepafloxacin and Its Glucuronide in Rats J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 1033 - 1039. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y.-P. Lu, Z.-S. Li, Y. M. Drozdowicz, S. Hortensteiner, E. Martinoia, and P. A. Rea AtMRP2, an Arabidopsis ATP Binding Cassette Transporter Able to Transport Glutathione S-Conjugates and Chlorophyll Catabolites: Functional Comparisons with AtMRP1 PLANT CELL, February 1, 1998; 10(2): 267 - 282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ito, H. Suzuki, T. Hirohashi, K. Kume, T. Shimizu, and Y. Sugiyama Functional Analysis of a Canalicular Multispecific Organic Anion Transporter Cloned from Rat Liver J. Biol. Chem., January 16, 1998; 273(3): 1684 - 1688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yamazaki, S. Akiyama, K. Ni'inuma, R. Nishigaki, and Y. Sugiyama Biliary Excretion of Pravastatin in Rats: Contribution of the excretion pathway mediated by canalicular multispecific organic anion transporter (CMOAT) Drug Metab. Dispos., October 1, 1997; 25(10): 1123 - 1129. [Abstract] [Full Text]
|
|
|
|
|
|
K. Niinuma, O. Takenaka, T. Horie, K. Kobayashi, Y. Kato, H. Suzuki, and Y. Sugiyama Kinetic Analysis of the Primary Active Transport of Conjugated Metabolites Across the Bile Canalicular Membrane: Comparative Study of S-(2,4-Dinitrophenyl)-glutathione and 6-Hydroxy-5,7-dimethyl-2-methylamino4-(3-pyridylmethyl)benzothiazole Glucuronide J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 866 - 872. [Abstract] [Full Text]
|
|
|
|
|
|
X.-Y. Chu, Y. Kato, K. Niinuma, K.-I. Sudo, H. Hakusui, and Y. Sugiyama Multispecific Organic Anion Transporter Is Responsible for the Biliary Excretion of the Camptothecin Derivative Irinotecan and its Metabolites in Rats J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 304 - 314. [Abstract] [Full Text]
|
|
|
|
|
|
H. Ishizuka, K. Konno, H. Naganuma, K. Sasahara, Y. Kawahara, K. Niinuma, H. Suzuki, and Y. Sugiyama Temocaprilat, a Novel Angiotensin-Converting Enzyme Inhibitor, is Excreted in Bile via an ATP-dependent Active Transporter (cMOAT) That is Deficient in Eisai Hyperbilirubinemic Mutant Rats (EHBR) J. Pharmacol. Exp. Ther., March 1, 1997; 280(3): 1304 - 1311. [Abstract] [Full Text]
|
|
|
|
|
|
D. W. Loe, K. C. Almquist, S. P. C. Cole, and R. G. Deeley ATP-dependent 17beta-Estradiol 17-(beta-D-Glucuronide) Transport by Multidrug Resistance Protein (MRP) J. Biol. Chem., April 19, 1996; 271(16): 9683 - 9689. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
